JP2015524812A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524812A5
JP2015524812A5 JP2015524470A JP2015524470A JP2015524812A5 JP 2015524812 A5 JP2015524812 A5 JP 2015524812A5 JP 2015524470 A JP2015524470 A JP 2015524470A JP 2015524470 A JP2015524470 A JP 2015524470A JP 2015524812 A5 JP2015524812 A5 JP 2015524812A5
Authority
JP
Japan
Prior art keywords
cis
trifluoromethyl
naphthalen
oxy
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015524470A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015524812A (ja
JP6391571B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/052316 external-priority patent/WO2014018881A1/en
Publication of JP2015524812A publication Critical patent/JP2015524812A/ja
Publication of JP2015524812A5 publication Critical patent/JP2015524812A5/ja
Application granted granted Critical
Publication of JP6391571B2 publication Critical patent/JP6391571B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015524470A 2012-07-27 2013-07-26 Atx調節剤 Expired - Fee Related JP6391571B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261676705P 2012-07-27 2012-07-27
US61/676,705 2012-07-27
PCT/US2013/052316 WO2014018881A1 (en) 2012-07-27 2013-07-26 Atx modulating agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018088836A Division JP2018135379A (ja) 2012-07-27 2018-05-02 Atx調節剤

Publications (3)

Publication Number Publication Date
JP2015524812A JP2015524812A (ja) 2015-08-27
JP2015524812A5 true JP2015524812A5 (cg-RX-API-DMAC7.html) 2016-09-08
JP6391571B2 JP6391571B2 (ja) 2018-09-19

Family

ID=49997862

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015524470A Expired - Fee Related JP6391571B2 (ja) 2012-07-27 2013-07-26 Atx調節剤
JP2018088836A Pending JP2018135379A (ja) 2012-07-27 2018-05-02 Atx調節剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018088836A Pending JP2018135379A (ja) 2012-07-27 2018-05-02 Atx調節剤

Country Status (22)

Country Link
US (2) US9522889B2 (cg-RX-API-DMAC7.html)
EP (1) EP2877166B1 (cg-RX-API-DMAC7.html)
JP (2) JP6391571B2 (cg-RX-API-DMAC7.html)
KR (1) KR102127026B1 (cg-RX-API-DMAC7.html)
CN (1) CN104768541B (cg-RX-API-DMAC7.html)
AR (1) AR091930A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013295584B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015001759A8 (cg-RX-API-DMAC7.html)
CA (1) CA2879360C (cg-RX-API-DMAC7.html)
CL (1) CL2015000209A1 (cg-RX-API-DMAC7.html)
CO (1) CO7350623A2 (cg-RX-API-DMAC7.html)
DK (1) DK2877166T3 (cg-RX-API-DMAC7.html)
EA (1) EA028364B1 (cg-RX-API-DMAC7.html)
ES (1) ES2668694T3 (cg-RX-API-DMAC7.html)
IL (1) IL236693B (cg-RX-API-DMAC7.html)
MX (1) MX363388B (cg-RX-API-DMAC7.html)
MY (1) MY171486A (cg-RX-API-DMAC7.html)
NZ (1) NZ703852A (cg-RX-API-DMAC7.html)
PH (1) PH12015500181B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201500339XA (cg-RX-API-DMAC7.html)
TW (1) TWI616430B (cg-RX-API-DMAC7.html)
WO (1) WO2014018881A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104364239B (zh) 2012-06-13 2017-08-25 霍夫曼-拉罗奇有限公司 二氮杂螺环烷烃和氮杂螺环烷烃
TWI616430B (zh) * 2012-07-27 2018-03-01 百健Ma公司 Atx調節劑
US9555050B2 (en) 2012-07-27 2017-01-31 Biogen Ma Inc. ATX modulating agents
JP6324380B2 (ja) 2012-07-27 2018-05-16 バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. S1p調節剤および/またはatx調節剤である化合物
EP2879674B1 (en) 2012-08-06 2017-11-22 Biogen MA Inc. Compounds that are s1p modulating agents and/or atx modulating agents
US9499485B2 (en) 2012-08-06 2016-11-22 Biogen Ma Inc. Compounds that are S1P modulating agents and/or ATX modulating agents
MX368615B (es) 2012-09-25 2019-10-09 Hoffmann La Roche Derivados bicíclicos como inhibidores de la autotaxina (atx) que son inhibidores de la producción de ácido lisofosfatídico (lpa) y el uso de los mismos.
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
DK3074400T3 (en) 2013-11-26 2018-01-15 Hoffmann La Roche Octahydro-cyclobuta [1,2-c; 3,4-c '] dipyrrole derivatives as autotaxin inhibitors
CA2937616A1 (en) 2014-03-26 2015-10-01 F. Hoffmann-La Roche Ag Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
EA032357B1 (ru) 2014-03-26 2019-05-31 Ф. Хоффманн-Ля Рош Аг Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
GB201501870D0 (en) 2015-02-04 2015-03-18 Cancer Rec Tech Ltd Autotaxin inhibitors
GB201502020D0 (en) 2015-02-06 2015-03-25 Cancer Rec Tech Ltd Autotaxin inhibitory compounds
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
AU2016270373A1 (en) 2015-06-05 2018-01-04 Vertex Pharmaceuticals Incorporated Triazoles for the treatment of demyelinating diseases
CA2992889A1 (en) 2015-09-04 2017-03-09 F. Hoffmann-La Roche Ag Phenoxymethyl derivatives
JP6876685B2 (ja) 2015-09-24 2021-05-26 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Atx阻害剤としての二環式化合物
WO2017050732A1 (en) 2015-09-24 2017-03-30 F. Hoffmann-La Roche Ag Bicyclic compounds as atx inhibitors
BR112017026682A2 (pt) 2015-09-24 2018-08-14 Hoffmann La Roche novos compostos bicíclicos como inibidores de dupla ação de atx/ca
AU2016328436B2 (en) 2015-09-24 2020-05-14 F. Hoffmann-La Roche Ag New bicyclic compounds as dual ATX/CA inhibitors
WO2018106643A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Heterocyclic azoles for the treatment of demyelinating diseases
WO2018106641A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Pyrazoles for the treatment of demyelinating diseases
WO2018106646A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Aminotriazoles for the treatment of demyelinating diseases
RU2019132254A (ru) 2017-03-16 2021-04-16 Ф. Хоффманн-Ля Рош Аг Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca
JP7090099B2 (ja) 2017-03-16 2022-06-23 エフ.ホフマン-ラ ロシュ アーゲー Atxインヒビターとしての新規二環式化合物
TW201908311A (zh) 2017-06-13 2019-03-01 英商葛蘭素史克智慧財產發展有限公司 化合物
IL284994B2 (en) 2019-02-01 2024-10-01 Wuhan Humanwell Innovative Drug Res And Development Center Limited Company Pyrrolopyrimidine derivative and use thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5219837A (en) 1990-06-21 1993-06-15 Trustees Of The University Of Pennsylvania Method of stimulating myelination of cells
IL135495A (en) 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
CZ20031145A3 (cs) * 2000-10-02 2003-12-17 Janssen Pharmaceutica N.V. Antagonisté metabotropního glutamátového receptoru
CA2479109C (en) 2002-03-29 2011-08-02 Janssen Pharmaceutica N.V. Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
WO2004108681A1 (en) * 2003-06-06 2004-12-16 Fibrogen, Inc. Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
GEP20084439B (en) 2004-01-23 2008-07-25 Amgen Inc Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
BRPI0519012A2 (pt) * 2004-12-13 2008-12-23 Ono Pharmaceutical Co derivado do Ácido aminocarboxÍlico e seu uso medicinal
WO2007067444A1 (en) * 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Bicyclic compounds with kinase inhibitory activity
BRPI0707302B8 (pt) * 2006-01-27 2021-05-25 Fibrogen Inc compostos de cianoisoquinolina que atuam no dano tecidual associado com isquemia, hipóxia e anemia, bem como composição farmacêutica que os compreende
CA2651072A1 (en) * 2006-05-01 2007-11-08 Pfizer Products Inc. Substituted 2-amino-fused heterocyclic compounds
WO2009023854A1 (en) * 2007-08-15 2009-02-19 University Of Virginia Patent Foundation Bicyclic sphingosine 1-phosphate analogs
WO2010051030A1 (en) * 2008-10-30 2010-05-06 Biogen Idec Ma Inc. Bicyclic aryl sphingosine 1-phosphate analogs
EP2364089B1 (en) * 2008-10-30 2016-12-07 Biogen MA Inc. Heterobicyclic sphingosine 1-phosphate analogs
PE20120578A1 (es) * 2009-02-10 2012-06-17 Abbott Lab Agonistas y antagonistas del receptor de s1p5, y metodos de uso de los mismos
UA107360C2 (en) 2009-08-05 2014-12-25 Biogen Idec Inc Bicyclic aryl sphingosine 1-phosphate analogs
EP2575794A2 (en) 2010-06-04 2013-04-10 B.S.R.C. "Alexander Fleming" Autotaxin pathway modulation and uses thereof
EA034451B1 (ru) * 2011-02-07 2020-02-10 Байоджен Ма Инк. Модуляторы s1p
EP2673277A1 (en) * 2011-02-10 2013-12-18 Novartis AG [1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase
TWI616430B (zh) * 2012-07-27 2018-03-01 百健Ma公司 Atx調節劑
JP6324380B2 (ja) * 2012-07-27 2018-05-16 バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. S1p調節剤および/またはatx調節剤である化合物
US9555050B2 (en) * 2012-07-27 2017-01-31 Biogen Ma Inc. ATX modulating agents
EP2879674B1 (en) * 2012-08-06 2017-11-22 Biogen MA Inc. Compounds that are s1p modulating agents and/or atx modulating agents
US9499485B2 (en) * 2012-08-06 2016-11-22 Biogen Ma Inc. Compounds that are S1P modulating agents and/or ATX modulating agents
TW201408658A (zh) * 2012-08-27 2014-03-01 Array Biopharma Inc 絲胺酸/酥胺酸激酶抑制劑
ES2749467T3 (es) * 2012-11-20 2020-03-20 Biogen Ma Inc Agentes moduladores de S1p y/o ATX
CA2899322A1 (en) * 2013-01-29 2014-08-07 Biogen Ma Inc. S1p modulating agents

Similar Documents

Publication Publication Date Title
JP2015524812A5 (cg-RX-API-DMAC7.html)
US11129834B2 (en) Combinations and methods comprising a capsid assembly inhibitor
AR083933A1 (es) Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
RU2015108898A (ru) 3-ЦИКЛОГЕКСЕНИЛ И ЦИКЛОГЕКСИЛ ЗАМЕЩЕННЫЕ ИНДОЛЬНЫЕ И ИНДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ RORгаммаТ И ИХ ПРИМЕНЕНИЯ
WO2022235859A1 (en) Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitors
RU2321588C2 (ru) Карбаматные производные хинуклидина, фармацевтическая композиция на их основе и применение
JP2014505696A5 (cg-RX-API-DMAC7.html)
MA27475A1 (fr) Composes de pyrazolo [3,4-b] pyridine et leur utilisation en tant qu'inhibiteurs de phosphodiesterase
RU2012103487A (ru) Ингибирующие jak соединения на основе пиразолопиримидина и способы
JP2013523889A5 (cg-RX-API-DMAC7.html)
NZ592685A (en) Modulators of cystic fibrosis transmembrane conductance regulator
RU2015102531A (ru) Офтальмологический состав и способ для облегчения пресбиопии
SI3004106T1 (en) Dual selective PI3 delta and gamma inhibitors
JP2013510124A5 (cg-RX-API-DMAC7.html)
RU2013105444A (ru) Конденсированные гетероциклические производные в качестве модуляторов s1p
TW201811733A (zh) 稠合三環γ-胺基酸衍生物、其製備方法及其在醫藥上的應用
JP2013542261A5 (cg-RX-API-DMAC7.html)
RU2007120454A (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
JP2011500621A5 (cg-RX-API-DMAC7.html)
JP2011511089A5 (cg-RX-API-DMAC7.html)
WO2017176962A1 (en) Pyrrolo[1,2-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
NZ583823A (en) Furazanes for enhancing glutamatergic synaptic responses
JP2011504936A5 (cg-RX-API-DMAC7.html)
RU2017133660A (ru) Новые гетероциклические соединения и их применение в профилактике или лечении бактериальных инфекций
RU2013153898A (ru) Новые гексагидроциклопентапирролоны, гексагидропирролопирролоны, октагидропирролопиридиноны и октагидропиридиноны